{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T15:22:51Z","timestamp":1780413771914,"version":"3.54.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["2054\/18"],"award-info":[{"award-number":["2054\/18"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["506\/13"],"award-info":[{"award-number":["506\/13"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.eplepsyres.2021.106664","type":"journal-article","created":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T11:25:07Z","timestamp":1620473107000},"page":"106664","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Effects of antiseizure medications on placental cells: Focus on heterodimeric placental carriers"],"prefix":"10.1016","volume":"174","author":[{"given":"Nino","family":"Tetro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4939-7171","authenticated-orcid":false,"given":"Roua","family":"Hamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8745-7120","authenticated-orcid":false,"given":"Erez","family":"Berman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Eyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2021.106664_bib0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/jmi.12133","article-title":"Cell-death assessment by fluorescent and nonfluorescent cytosolic and nuclear staining techniques","volume":"255","author":"Atale","year":"2014","journal-title":"J. Microsc."},{"key":"10.1016\/j.eplepsyres.2021.106664_bib0010","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.cell.2015.07.022","article-title":"A call for systematic research on solute carriers","volume":"162","author":"Cesar-Razquin","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.eplepsyres.2021.106664_bib0015","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ejps.2008.06.015","article-title":"Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2","volume":"35","author":"Del Amo","year":"2008","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.eplepsyres.2021.106664_bib0020","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/bdra.23277","article-title":"Brief report novel mechanism for valproate-induced teratogenicity","volume":"100","author":"Fathe","year":"2014","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.eplepsyres.2021.106664_bib0025","doi-asserted-by":"crossref","first-page":"9690","DOI":"10.1074\/jbc.275.13.9690","article-title":"Identification and characterization of a Na+-independent neutral amino acid transporter that associates with the 4F2 heavy chain and exhibits substrate selectivity for small neutral d- and l-Amino acids*","volume":"275","author":"Fukasawa","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.eplepsyres.2021.106664_bib0030","first-page":"3809","article-title":"Isolation and structural characterization of the human 4F2 heavy-chain gene, an inducible gene involved in T-lymphocyte activation","volume":"8","author":"Gottesdiener","year":"1988","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.eplepsyres.2021.106664_bib0035","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.dmpk.2020.01.005","article-title":"Cellular uptake properties of lamotrigine in human placental cell lines: investigation of involvement of organic cation transporters (SLC22A1-5)","volume":"35","author":"Hasegawa","year":"2020","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.eplepsyres.2021.106664_bib0040","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/ana.25031","article-title":"Fetal growth and premature delivery in pregnant women on antiepileptic drugs","volume":"82","author":"Hernandez-Diaz","year":"2017","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.eplepsyres.2021.106664_bib0045","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1203\/00006450-199810000-00011","article-title":"Placental transport of leucine and lysine is reduced in intrauterine growth restriction","volume":"44","author":"Jansson","year":"1998","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.eplepsyres.2021.106664_bib0050","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.reprotox.2020.04.077","article-title":"Effects of single and repetitive valproic acid administration on the gene expression of placental transporters in pregnant rats: an analysis by gestational period","volume":"96","author":"Jinno","year":"2020","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.eplepsyres.2021.106664_bib0055","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1528-1167.2005.54804.x","article-title":"Levetiracetam concentrations in serum and in breast milk at birth and during lactation","volume":"46","author":"Johannessen","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2021.106664_bib0060","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/17425255.2020.1724956","article-title":"Therapeutic drug monitoring of antiepileptic drugs: current status and future prospects","volume":"16","author":"Johannessen Landmark","year":"2020","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.eplepsyres.2021.106664_bib0065","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.yebeh.2016.10.014","article-title":"Cognitive functions in children exposed to antiepileptic drugs in utero - Study in Georgia","volume":"66","author":"Kasradze","year":"2017","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2021.106664_bib0070","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1113\/jphysiol.2003.040550","article-title":"Manipulation of CD98 expression affects both trophoblast cell fusion and amino acid transport activity during syncytialization of human placental BeWo cells","volume":"550","author":"Kudo","year":"2003","journal-title":"J. Physiol."},{"key":"10.1016\/j.eplepsyres.2021.106664_bib0075","doi-asserted-by":"crossref","first-page":"C263","DOI":"10.1152\/ajpcell.00333.2003","article-title":"L-Carnitine transport in human placental brush-border membranes is mediated by the sodium-dependent organic cation transporter OCTN2","volume":"287","author":"Lahjouji","year":"2004","journal-title":"Am. J. Physiol., Cell Physiol."},{"key":"10.1016\/j.eplepsyres.2021.106664_bib0080","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1111\/epi.16055","article-title":"Anticonvulsant and antiepileptogenic effects of system xc- inactivation in chronic epilepsy models","volume":"60","author":"Leclercq","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2021.106664_bib0085","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nrd4626","article-title":"SLC transporters as therapeutic targets: emerging opportunities","volume":"14","author":"Lin","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.eplepsyres.2021.106664_bib0090","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1203\/00006450-199907000-00019","article-title":"Steady state maternal-fetal leucine enrichments in normal and intrauterine growth-restricted pregnancies","volume":"46","author":"Marconi","year":"1999","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.eplepsyres.2021.106664_bib0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0214180","article-title":"Relation of in-utero exposure to antiepileptic drugs to pregnancy duration and size at birth","volume":"14","author":"Margulis","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.eplepsyres.2021.106664_bib0100","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.tem.2013.01.002","article-title":"Nutrient transporters: the Achilles\u2019 heel of anabolism","volume":"24","author":"McCracken","year":"2013","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.eplepsyres.2021.106664_bib0105","doi-asserted-by":"crossref","first-page":"15s","DOI":"10.1177\/1535759720945298","article-title":"Teratogenicity and antiseizure medications","volume":"20","author":"Meador","year":"2020","journal-title":"Epilepsy Curr."},{"key":"10.1016\/j.eplepsyres.2021.106664_bib0110","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S1474-4422(12)70323-X","article-title":"Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study","volume":"12","author":"Meador","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.eplepsyres.2021.106664_bib0115","doi-asserted-by":"crossref","first-page":"e1502","DOI":"10.1212\/WNL.0000000000008687","article-title":"Fetal loss and malformations in the MONEAD study of pregnant women with epilepsy","volume":"94","author":"Meador","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2021.106664_bib0120","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1111\/epi.13392","article-title":"Effects of valproic acid on the placental barrier in the pregnant mouse: optical imaging and transporter expression studies","volume":"57","author":"Meir","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2021.106664_bib0125","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/jnc.13405","article-title":"Neuroprotective effects of levetiracetam target xCT in astrocytes in parkinsonian mice","volume":"136","author":"Miyazaki","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.eplepsyres.2021.106664_bib0130","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1111\/j.1528-1167.2005.00251.x","article-title":"Pharmacokinetics of gabapentin during delivery, in the neonatal period, and lactation: Does a fetal accumulation occur during pregnancy?","volume":"46","author":"Ohman","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2021.106664_bib0135","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.placenta.2018.11.010","article-title":"Analysis of the effects of polyunsaturated fatty acids on transporter expressions using a PCR array: induction of xCT\/SLC7A11 in human placental BeWo cells","volume":"75","author":"Ono","year":"2019","journal-title":"Placenta"},{"key":"10.1016\/j.eplepsyres.2021.106664_bib0140","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.placenta.2020.10.034","article-title":"Differential expression of system L amino acid transporter subtypes in rat placenta and yolk sac","volume":"103","author":"Owaydhah","year":"2021","journal-title":"Placenta"},{"key":"10.1016\/j.eplepsyres.2021.106664_bib0145","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nature22379","article-title":"Nutrient acquisition strategies of mammalian cells","volume":"546","author":"Palm","year":"2017","journal-title":"Nature."},{"key":"10.1016\/j.eplepsyres.2021.106664_bib0150","doi-asserted-by":"crossref","first-page":"5427","DOI":"10.1210\/jcem.86.11.8036","article-title":"Placental transport of leucine, phenylalanine, glycine, and proline in intrauterine growth-restricted pregnancies","volume":"86","author":"Paolini","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.eplepsyres.2021.106664_bib0155","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/epi.13037","article-title":"Antiepileptic drugs alter the expression of placental carriers: an in vitro study in a human placental cell line","volume":"56","author":"Rubinchik-Stern","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2021.106664_bib0160","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/epi.14078","article-title":"Adverse placental effects of valproic acid: studies in perfused human placentas","volume":"59","author":"Rubinchik-Stern","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2021.106664_bib0165","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/epi4.12307","article-title":"Decreased epileptogenesis in mice lacking the System x(c) (-) transporter occurs in association with a reduction in AMPA receptor subunit GluA1","volume":"4","author":"Sears","year":"2019","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.eplepsyres.2021.106664_bib0170","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.eplepsyres.2018.11.010","article-title":"Antiepileptic drug treatment during pregnancy and delivery in women with epilepsy-A retrospective single center study","volume":"149","author":"Shihman","year":"2018","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2021.106664_bib0175","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.placenta.2017.10.010","article-title":"DNA methylation of amino acid transporter genes in the human placenta","volume":"60","author":"Simner","year":"2017","journal-title":"Placenta"},{"key":"10.1016\/j.eplepsyres.2021.106664_bib0180","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S1474-4422(18)30495-2","article-title":"Management of epilepsy in women","volume":"18","author":"Stephen","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.eplepsyres.2021.106664_bib0185","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11095-017-2286-0","article-title":"The placental barrier: the gate and the fate in drug distribution","volume":"35","author":"Tetro","year":"2018","journal-title":"Pharm. Res."},{"key":"10.1016\/j.eplepsyres.2021.106664_bib0190","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1111\/epi.14721","article-title":"The effects of valproic acid on early pregnancy human placentas: pilot ex vivo analysis in cultured placental villi","volume":"60","author":"Tetro","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2021.106664_bib0195","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ccr.2013.08.020","article-title":"Glutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic target","volume":"24","author":"Timmerman","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.eplepsyres.2021.106664_bib0200","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1474-4422(11)70107-7","article-title":"Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry","volume":"10","author":"Tomson","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.eplepsyres.2021.106664_bib0205","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S1474-4422(18)30107-8","article-title":"Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry","volume":"17","author":"Tomson","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.eplepsyres.2021.106664_bib0210","doi-asserted-by":"crossref","first-page":"e831","DOI":"10.1212\/WNL.0000000000008001","article-title":"Declining malformation rates with changed antiepileptic drug prescribing: an observational study","volume":"93","author":"Tomson","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2021.106664_bib0215","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.taap.2018.12.001","article-title":"Metabolome-wide association study of anti-epileptic drug treatment during pregnancy","volume":"363","author":"Walker","year":"2019","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2021.106664_bib0220","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.0013-9580.2004.29603.x","article-title":"Interaction between anticonvulsants and human placental carnitine transporter","volume":"45","author":"Wu","year":"2004","journal-title":"Epilepsia"}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121121001170?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121121001170?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T20:28:34Z","timestamp":1777580914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121121001170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":44,"alternative-id":["S0920121121001170"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2021.106664","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of antiseizure medications on placental cells: Focus on heterodimeric placental carriers","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2021.106664","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106664"}}